SAVA
Cassava Sciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$114.97M
P/E Ratio
—
EPS
$-2.22
Beta
-0.84
52W High
$4.98
52W Low
$1.20
50-Day MA
$2.11
200-Day MA
$2.52
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
151.52
PEG Ratio
1.62
About Cassava Sciences Inc
Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-43.27M |
| EBITDA | $-69.30M |
| Operating Margin | 0.00% |
| Return on Equity | -85.40% |
| Return on Assets | -24.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.69 |
| Price-to-Book | 0.92 |
| Price-to-Sales (TTM) | 2.54 |
| EV/Revenue | 1.333 |
| EV/EBITDA | 2.08 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $48.31M |
| Float | $42.98M |
| % Insiders | 12.79% |
| % Institutions | 28.98% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
More HEALTHCARE Stocks
Data last updated: 6/13/2026